Global Colloids (Blood Plasma) Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Colloids (Blood Plasma) Market
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.

Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.

Due to the COVID-19 pandemic, the global Colloids (Blood Plasma) market size is estimated to be worth US$ 395.7 million in 2022 and is forecast to a readjusted size of US$ 339.9 million by 2028 with a CAGR of -2.5% during the review period. Fully considering the economic change by this health crisis, Natural Type Colloids (Blood Plasma) accounting for % of the Colloids (Blood Plasma) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Extensive Burns segment is altered to an % CAGR throughout this forecast period.

North America is the largest Colloids (Blood Plasma) market with about 33% market share. Europe is follower, accounting for about 28% market share.

The key players are CSL Behring, Baxter, Grifols, Octapharma, Kedrion, Shanghai Raas, CTBB, Hualan Bio, Rongsheng Pharmaceutical, Boya Rongsheng, B. Braun Medical, Fresenius Kabi, HOSPIRA, Axa parenterals, Fresenius Kabi(China), CR Double-Crane, Kelun Group, Shandong Qidu Pharmaceutical, Shandong Hualu Pharmaceutical, Minsheng Pharma, Kanglepharm etc. Top 3 companies occupied about 46% market share.

Market Segments

The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.

Segment by Type

Natural Type Colloids (Blood Plasma)

Synthetic Type Colloids (Blood Plasma)

Segment by Application

Extensive Burns

Massive Blood or Plasma Loss

Hypovolemic Shock

Others

Consequence of Covid-19 Pandemic

The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Colloids (Blood Plasma) market back to the pre-covid levels.

Trends & Prospects

In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

Competitive Outlook

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

CSL Behring

Baxter

Grifols

Octapharma

Kedrion

Shanghai Raas

CTBB

Hualan Bio

Rongsheng Pharmaceutical

Boya Rongsheng

B. Braun Medical

Fresenius Kabi

HOSPIRA

Axa parenterals

Fresenius Kabi (China)

CR Double-Crane

Kelun Group

Shandong Qidu Pharmaceutical

Shandong Hualu Pharmaceutical

Minsheng Pharma

Kanglepharm

TABLE OF CONTENT

1 Study Coverage
1.1 Colloids (Blood Plasma) Product Introduction

1.2 Market by Type

1.2.1 Global Colloids (Blood Plasma) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Natural Type Colloids (Blood Plasma)

1.2.3 Synthetic Type Colloids (Blood Plasma)

1.3 Market by Application

1.3.1 Global Colloids (Blood Plasma) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Extensive Burns

1.3.3 Massive Blood or Plasma Loss

1.3.4 Hypovolemic Shock

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Colloids (Blood Plasma) Sales Estimates and Forecasts 2017-2028

2.2 Global Colloids (Blood Plasma) Revenue Estimates and Forecasts 2017-2028

2.3 Global Colloids (Blood Plasma) Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Colloids (Blood Plasma) Sales by Region

2.4.1 Global Colloids (Blood Plasma) Sales by Region (2017-2022)

2.4.2 Global Sales Colloids (Blood Plasma) by Region (2023-2028)

2.5 Global Colloids (Blood Plasma) Revenue by Region

2.5.1 Global Colloids (Blood Plasma) Revenue by Region (2017-2022)

2.5.2 Global Colloids (Blood Plasma) Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Colloids (Blood Plasma) Sales by Manufacturers

3.1.1 Global Top Colloids (Blood Plasma) Manufacturers by Sales (2017-2022)

3.1.2 Global Colloids (Blood Plasma) Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Colloids (Blood Plasma) in 2021

3.2 Global Colloids (Blood Plasma) Revenue by Manufacturers

3.2.1 Global Colloids (Blood Plasma) Revenue by Manufacturers (2017-2022)

3.2.2 Global Colloids (Blood Plasma) Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Colloids (Blood Plasma) Revenue in 2021

3.3 Global Colloids (Blood Plasma) Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Colloids (Blood Plasma) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Colloids (Blood Plasma) Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Colloids (Blood Plasma) Sales by Type

4.1.1 Global Colloids (Blood Plasma) Historical Sales by Type (2017-2022)

4.1.2 Global Colloids (Blood Plasma) Forecasted Sales by Type (2023-2028)

4.1.3 Global Colloids (Blood Plasma) Sales Market Share by Type (2017-2028)

4.2 Global Colloids (Blood Plasma) Revenue by Type

4.2.1 Global Colloids (Blood Plasma) Historical Revenue by Type (2017-2022)

4.2.2 Global Colloids (Blood Plasma) Forecasted Revenue by Type (2023-2028)

4.2.3 Global Colloids (Blood Plasma) Revenue Market Share by Type (2017-2028)

4.3 Global Colloids (Blood Plasma) Price by Type

4.3.1 Global Colloids (Blood Plasma) Price by Type (2017-2022)

4.3.2 Global Colloids (Blood Plasma) Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Colloids (Blood Plasma) Sales by Application

5.1.1 Global Colloids (Blood Plasma) Historical Sales by Application (2017-2022)

5.1.2 Global Colloids (Blood Plasma) Forecasted Sales by Application (2023-2028)

5.1.3 Global Colloids (Blood Plasma) Sales Market Share by Application (2017-2028)

5.2 Global Colloids (Blood Plasma) Revenue by Application

5.2.1 Global Colloids (Blood Plasma) Historical Revenue by Application (2017-2022)

5.2.2 Global Colloids (Blood Plasma) Forecasted Revenue by Application (2023-2028)

5.2.3 Global Colloids (Blood Plasma) Revenue Market Share by Application (2017-2028)

5.3 Global Colloids (Blood Plasma) Price by Application

5.3.1 Global Colloids (Blood Plasma) Price by Application (2017-2022)

5.3.2 Global Colloids (Blood Plasma) Price Forecast by Application (2023-2028)

6 North America

6.1 North America Colloids (Blood Plasma) Market Size by Type

6.1.1 North America Colloids (Blood Plasma) Sales by Type (2017-2028)

6.1.2 North America Colloids (Blood Plasma) Revenue by Type (2017-2028)

6.2 North America Colloids (Blood Plasma) Market Size by Application

6.2.1 North America Colloids (Blood Plasma) Sales by Application (2017-2028)

6.2.2 North America Colloids (Blood Plasma) Revenue by Application (2017-2028)

6.3 North America Colloids (Blood Plasma) Market Size by Country

6.3.1 North America Colloids (Blood Plasma) Sales by Country (2017-2028)

6.3.2 North America Colloids (Blood Plasma) Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Colloids (Blood Plasma) Market Size by Type

7.1.1 Europe Colloids (Blood Plasma) Sales by Type (2017-2028)

7.1.2 Europe Colloids (Blood Plasma) Revenue by Type (2017-2028)

7.2 Europe Colloids (Blood Plasma) Market Size by Application

7.2.1 Europe Colloids (Blood Plasma) Sales by Application (2017-2028)

7.2.2 Europe Colloids (Blood Plasma) Revenue by Application (2017-2028)

7.3 Europe Colloids (Blood Plasma) Market Size by Country

7.3.1 Europe Colloids (Blood Plasma) Sales by Country (2017-2028)

7.3.2 Europe Colloids (Blood Plasma) Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Colloids (Blood Plasma) Market Size by Type

8.1.1 Asia Pacific Colloids (Blood Plasma) Sales by Type (2017-2028)

8.1.2 Asia Pacific Colloids (Blood Plasma) Revenue by Type (2017-2028)

8.2 Asia Pacific Colloids (Blood Plasma) Market Size by Application

8.2.1 Asia Pacific Colloids (Blood Plasma) Sales by Application (2017-2028)

8.2.2 Asia Pacific Colloids (Blood Plasma) Revenue by Application (2017-2028)

8.3 Asia Pacific Colloids (Blood Plasma) Market Size by Region

8.3.1 Asia Pacific Colloids (Blood Plasma) Sales by Region (2017-2028)

8.3.2 Asia Pacific Colloids (Blood Plasma) Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

8.3.12 Philippines

9 Latin America

9.1 Latin America Colloids (Blood Plasma) Market Size by Type

9.1.1 Latin America Colloids (Blood Plasma) Sales by Type (2017-2028)

9.1.2 Latin America Colloids (Blood Plasma) Revenue by Type (2017-2028)

9.2 Latin America Colloids (Blood Plasma) Market Size by Application

9.2.1 Latin America Colloids (Blood Plasma) Sales by Application (2017-2028)

9.2.2 Latin America Colloids (Blood Plasma) Revenue by Application (2017-2028)

9.3 Latin America Colloids (Blood Plasma) Market Size by Country

9.3.1 Latin America Colloids (Blood Plasma) Sales by Country (2017-2028)

9.3.2 Latin America Colloids (Blood Plasma) Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Colloids (Blood Plasma) Market Size by Type

10.1.1 Middle East and Africa Colloids (Blood Plasma) Sales by Type (2017-2028)

10.1.2 Middle East and Africa Colloids (Blood Plasma) Revenue by Type (2017-2028)

10.2 Middle East and Africa Colloids (Blood Plasma) Market Size by Application

10.2.1 Middle East and Africa Colloids (Blood Plasma) Sales by Application (2017-2028)

10.2.2 Middle East and Africa Colloids (Blood Plasma) Revenue by Application (2017-2028)

10.3 Middle East and Africa Colloids (Blood Plasma) Market Size by Country

10.3.1 Middle East and Africa Colloids (Blood Plasma) Sales by Country (2017-2028)

10.3.2 Middle East and Africa Colloids (Blood Plasma) Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 CSL Behring

11.1.1 CSL Behring Corporation Information

11.1.2 CSL Behring Overview

11.1.3 CSL Behring Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 CSL Behring Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 CSL Behring Recent Developments

11.2 Baxter

11.2.1 Baxter Corporation Information

11.2.2 Baxter Overview

11.2.3 Baxter Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Baxter Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Baxter Recent Developments

11.3 Grifols

11.3.1 Grifols Corporation Information

11.3.2 Grifols Overview

11.3.3 Grifols Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Grifols Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Grifols Recent Developments

11.4 Octapharma

11.4.1 Octapharma Corporation Information

11.4.2 Octapharma Overview

11.4.3 Octapharma Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Octapharma Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Octapharma Recent Developments

11.5 Kedrion

11.5.1 Kedrion Corporation Information

11.5.2 Kedrion Overview

11.5.3 Kedrion Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 Kedrion Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Kedrion Recent Developments

11.6 Shanghai Raas

11.6.1 Shanghai Raas Corporation Information

11.6.2 Shanghai Raas Overview

11.6.3 Shanghai Raas Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 Shanghai Raas Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Shanghai Raas Recent Developments

11.7 CTBB

11.7.1 CTBB Corporation Information

11.7.2 CTBB Overview

11.7.3 CTBB Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 CTBB Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 CTBB Recent Developments

11.8 Hualan Bio

11.8.1 Hualan Bio Corporation Information

11.8.2 Hualan Bio Overview

11.8.3 Hualan Bio Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 Hualan Bio Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Hualan Bio Recent Developments

11.9 Rongsheng Pharmaceutical

11.9.1 Rongsheng Pharmaceutical Corporation Information

11.9.2 Rongsheng Pharmaceutical Overview

11.9.3 Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2017-2022)

11.9.4 Rongsheng Pharmaceutical Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Rongsheng Pharmaceutical Recent Developments

11.10 Boya Rongsheng

11.10.1 Boya Rongsheng Corporation Information

11.10.2 Boya Rongsheng Overview

11.10.3 Boya Rongsheng Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2017-2022)

11.10.4 Boya Rongsheng Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Boya Rongsheng Recent Developments

11.11 B. Braun Medical

11.11.1 B. Braun Medical Corporation Information

11.11.2 B. Braun Medical Overview

11.11.3 B. Braun Medical Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2017-2022)

11.11.4 B. Braun Medical Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 B. Braun Medical Recent Developments

11.12 Fresenius Kabi

11.12.1 Fresenius Kabi Corporation Information

11.12.2 Fresenius Kabi Overview

11.12.3 Fresenius Kabi Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2017-2022)

11.12.4 Fresenius Kabi Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications

11.12.5 Fresenius Kabi Recent Developments

11.13 HOSPIRA

11.13.1 HOSPIRA Corporation Information

11.13.2 HOSPIRA Overview

11.13.3 HOSPIRA Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2017-2022)

11.13.4 HOSPIRA Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications

11.13.5 HOSPIRA Recent Developments

11.14 Axa parenterals

11.14.1 Axa parenterals Corporation Information

11.14.2 Axa parenterals Overview

11.14.3 Axa parenterals Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2017-2022)

11.14.4 Axa parenterals Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications

11.14.5 Axa parenterals Recent Developments

11.15 Fresenius Kabi (China)

11.15.1 Fresenius Kabi (China) Corporation Information

11.15.2 Fresenius Kabi (China) Overview

11.15.3 Fresenius Kabi (China) Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2017-2022)

11.15.4 Fresenius Kabi (China) Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications

11.15.5 Fresenius Kabi (China) Recent Developments

11.16 CR Double-Crane

11.16.1 CR Double-Crane Corporation Information

11.16.2 CR Double-Crane Overview

11.16.3 CR Double-Crane Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2017-2022)

11.16.4 CR Double-Crane Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications

11.16.5 CR Double-Crane Recent Developments

11.17 Kelun Group

11.17.1 Kelun Group Corporation Information

11.17.2 Kelun Group Overview

11.17.3 Kelun Group Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2017-2022)

11.17.4 Kelun Group Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications

11.17.5 Kelun Group Recent Developments

11.18 Shandong Qidu Pharmaceutical

11.18.1 Shandong Qidu Pharmaceutical Corporation Information

11.18.2 Shandong Qidu Pharmaceutical Overview

11.18.3 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2017-2022)

11.18.4 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications

11.18.5 Shandong Qidu Pharmaceutical Recent Developments

11.19 Shandong Hualu Pharmaceutical

11.19.1 Shandong Hualu Pharmaceutical Corporation Information

11.19.2 Shandong Hualu Pharmaceutical Overview

11.19.3 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2017-2022)

11.19.4 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications

11.19.5 Shandong Hualu Pharmaceutical Recent Developments

11.20 Minsheng Pharma

11.20.1 Minsheng Pharma Corporation Information

11.20.2 Minsheng Pharma Overview

11.20.3 Minsheng Pharma Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2017-2022)

11.20.4 Minsheng Pharma Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications

11.20.5 Minsheng Pharma Recent Developments

11.21 Kanglepharm

11.21.1 Kanglepharm Corporation Information

11.21.2 Kanglepharm Overview

11.21.3 Kanglepharm Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2017-2022)

11.21.4 Kanglepharm Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications

11.21.5 Kanglepharm Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Colloids (Blood Plasma) Industry Chain Analysis

12.2 Colloids (Blood Plasma) Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Colloids (Blood Plasma) Production Mode & Process

12.4 Colloids (Blood Plasma) Sales and Marketing

12.4.1 Colloids (Blood Plasma) Sales Channels

12.4.2 Colloids (Blood Plasma) Distributors

12.5 Colloids (Blood Plasma) Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Colloids (Blood Plasma) Industry Trends

13.2 Colloids (Blood Plasma) Market Drivers

13.3 Colloids (Blood Plasma) Market Challenges

13.4 Colloids (Blood Plasma) Market Restraints

14 Key Findings in The Global Colloids (Blood Plasma) Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

Choose License Type

Checkout Inquiry Sample